We studied the receptors on human cultured macrophages (MO-MO) 
Introduction
Infections due to the encapsulated yeastlike fungus Cryptococcus neoformans are significant causes ofmorbidity and mortality in patients with impaired cell-mediated immunity, especially those with AIDS (1) . Macrophages are thought to play a major role in host defenses against this opportunistic pathogen (2) (3) (4) (5) (6) . In the absence ofspecific antibody, a functional complement system has been shown to be required for binding of C. neoformans to human macrophages in vitro (7, 8) . C. neoformans is a potent activator of the complement cascade, with large amounts of C3, primarily in the form of iC3b, deposited on the surface ofthe capsule after incubation in normal human serum (8-1 1) . Binding by phagocytes of C. neoformans opsonized with human serum occurs at a relatively low rate com-pared with mutant yeasts lacking capsule, despite being covered with seemingly sufficient amounts of iC3b (5, 6, 12) . Whereas capsule confers upon C. neoformans a negative surface charge and a hydrophilic surface, the antibinding effects of capsule can be dissociated from these physicochemical properties (13, 14) .
Human monocyte-derived macrophages (MO-MO)' and other phagocytes have been shown to possess at least three distinct complement receptors (CR) that recognize C3 degradation fragments (reviewed in reference 15). CR1 (CD35) and CR3 (CDl lb/CD 1 8) have greatest affinity for particles coated with C3b and iC3b, respectively, whereas CR4 (CDlIc/CD 18, p 150,95) preferentially recognizes both iC3b-and C3dg-coated stimuli. Although CR3 and CR4 share a common P chain (CD18), their complement-binding activities have been localized to regions on their distinct a chains (15, 16) . These receptors can be differentiated on the basis of their reactivities to MAb, their sensitivities to proteases and their requirements for temperature and divalent cations (17) (18) (19) (20) . In addition to sites for binding complement, the a chain of CR3 also appears to have sites for binding f-glucans (21) , whereas the common , chain ofCR3, CR4, and LFA-l (the third member ofthe CD1 8 family) has been shown to play a role in cellular adhesion and in binding unopsonized Histoplasma capsulatum and bacterial endotoxin (18, 22, 23) .
Whether a microorganism is able to establish itself as a pathogen depends to a large extent upon which receptors on host cells bind to it, and the consequences of that binding. Therefore, in this paper, we investigated the requirements for binding (attachment) of serum-opsonized encapsulated and mutant acapsular strains of C. neoformans to MO-MO, and whether binding leads to actual phagocytosis (internalization). Assay to distinguished attachedfrom fully internalized organisms. The above binding assay does not distinguish between organisms bound to the surface of MO-M4 versus those that have been fully phagocytosed (internalized). To make this distinction, our previously described Uvitex assay, with slight modifications, was used (5, 25).
MO-MO were cultured as above, except in wells ofeight-chamber tissue culture slides (Lab-Tek, Miles Scientific) at 4 x I0 per well. After three washes with RPMI1640, MO-MO were challenged for 30 min at 370C with RITC-labeled C. neoformans in the presence of 10% PHS. Wells were washed with PBS, and the cells incubated with 0.1% Uvitex (diaethanol or Fungiqual, Ciba-Giegy, Basel, Switzerland) for 1 min at 230C. Wells were again washed in PBS and the cells fixed with 1% formaldehyde. Using an epifluorescent microscope, 200 cell-associated yeasts per well were identified after excitation at 546 nm, and then examined with UV excitation to determine which yeasts stained with Uvitex. Organisms that stain with Uvitex under these conditions are bound but not internalized, whereas those that do not stain are fully internalized (5, 25) . Bound only organisms were also distinguished from those internalized by examination under phase-contrast microscopy, as described (29) .
Immunofluorescence Figs. 2 and 3 ). Of the cell-associated serum-opsonized encapsulated organisms, only 23% were internalized by the MO-Mo. Depleting PHS of immunoglobulins reactive with C. neoformans did not significantly alter the percentage oforganisms internalized. However, when the yeasts were opsonized with specific anticapsular antibody, most of the bound organisms were internalized. In contrast, 88% of acapsular yeasts were completely internalized after opsonization in PHS alone, even if the PHS was depleted of immunoglobulins reactive with C. neoformans. Identical trends were observed using phase-contrast microscopy instead of the Uvitex assay (data not shown). Immunofluorescence studies were next performed to see whether CR could be localized to the region ofthe cryptococcal binding site. Under epifluorescent microscopy, intense staining of MO-MO incubated with either anti-leu-M5 (Fig. 4) (Table III) . Omission ofCa++ and Mg++ from the culture medium resulted in > 80% inhibition ofbinding of both cryptococcal strains.
Inhibition of binding by proteolytic enzymes. Trypsin and human neutrophil elastase both have been shown to affect expression and function of CR (19, 20, 32) . The effect of these proteases on MO-MO binding of C. neoformans was therefore investigated (Fig. 5, a and b opsonized erythrocytes to phagocytes does not require energy and occurs at 40C (18, 35) . We therefore studied whether the situation was similar for C. neoformans (Table IV) . For these experiments, a 5-min incubation was used. Preliminary experi- (Table V) .
Discussion
The data presented here provide several lines of evidence that, taken together, strongly suggest multiple CR are involved in binding of serum-opsonized C. neoformans by MO-M4. First, monoclonal antibodies directed against CR1, CR3, or CR4 each profoundly inhibited binding of serum-opsonized yeasts to MO-MO (Table II) MAb did not inhibit binding oforganisms opsonized with anticapsular Ig rather than PHS. Moreover, the MAb were specific in their effects on binding ofEC3b and EiC3b. Second, immunofluorescent studies localized CR3 and CR4 preferentially to the area of the cryptococcal binding site (Fig. 4) . Finally, profound inhibition of binding occurred under conditions where divalent cations were omitted from the system (Table III) . Divalent cations have been shown to be necessary for the binding of complement-coated particles by CR3 and CR4, but not CR 1 (17, 18, 30, 31) .
Cleavage of receptors with the proteases trypsin and human neutrophil elastase profoundly inhibited binding of encapsulated, and, to a lesser extent, acapsular C. neoformans to MO-MO (Fig. 5) . Treatment with either trypsin or human leukocyte elastase has been shown to cleave CR1, but not CR3, on activated human PMN as measured by FACS scanning (20, 32) . In preliminary studies in our laboratory, we have found that elas- (36, 37) . Moreover, a subset of plasma membrane CR3 has recently been described that appears to be involved in phagocytosis of particles by several different receptors including CR1 and FcR. This subset is attached to the cytoskeleton of the phagocyte and its function is inhibited by both cytochalasin and MAb directed at sites on CR3 distinct from the complement-binding site (39) . For FMLP receptors, receptor occupancy has been shown to lead to actin polymerization, and, concomitantly, conversion ofthe receptor complex from a fast dissociating to a slow dissociating form (40, 41). Thus, cytoskeletal changes could contribute to cryptococcal binding by increasing the affinity of CR for ligands on the yeast's surface. Recently, both attachment and phagocytosis of unopsonized Histoplasma capsulatum (but not complement-coated erythrocytes) to human MO-MO was shown to be inhibited by cytochalasin D (23) .
The requirements for multiple CR, energy, and actin may help explain why binding of serum-opsonized encapsulated C. neoformans is so inefficient, despite the dense accumulation of iC3b on the surface ofthe organism (8, 9, 1 1). However, it still remains unclear what factors on the organism contribute to this inefficient binding. For complement-coated erythrocytes, clustering of C3 fragments has been shown to lead to more efficient binding by phagocytes than when the C3 molecules are randomly distributed on the surface (42) . It is thus possible that the distribution of C3 fragments on the capsular surface thwarts efficient phagocytic binding. Alternatively, the site on the C3 molecule that interacts with the ligand-binding site on phagocytic CR may not be optimally exposed so that high-affinity binding can occur. Further studies on the molecular biology of complement activation and deposition on cryptococcal capsule are needed to answer these questions.
After binding of a particle to phagocytic receptor(s), internalization ofthe particle may or may not take place, depending upon the particular receptor(s) involved and its state of activation (24, 43) . Whereas FcR and mannose receptors constitutively phagocytose bound particles, CR do not, although under certain conditions they can be upregulated to do so (44) . Moreover, CR may collaborate with internalization-promoting receptors to phagocytose a particle. For example, mannose receptors can synergize with CR to efficiently internalize complement-coated zymosan or Leishmania donovani promastigotes and amastigotes (35, 44, 45) . Consistent with these observations, of the serum-opsonized encapsulated C. neoformans bound to MO-MO, only 23% actually was internalized (Table   I ). In contrast, 64 and 88% ofbound Ig-opsonized encapsulated and serum-opsonized acapsular C. neoformans, respectively, were internalized. The ability of MO-MO to phagocytose serum-opsonized acapsular yeasts likely relates to exposed mannans, ,B-glucans or other ligands exposed on the cell wall of the organism. Such cell wall ligands are masked from the surface of encapsulated organisms by capsule and thus are not available to bind to their appropriate rec~eptor. These phagocytosis data are consistent with results previously reported using mouse peritoneal macrophages (5, 29 
